GlaxoSmithKline Balance Sheet
View: Annual
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 8,138.2 | 6,745.5 | 3,926.2 |
| Net Receivables | 9,177.3 | 11,085.5 | 10,776.0 |
| Inventories | 5,870.2 | 6,112.7 | 4,772.1 |
| Other Current Assets | 1,807.7 | 3,258.0 | 2,050.2 |
| Total Current Assets | 24,993.4 | 27,201.6 | 21,524.5 |
| Net Fixed Assets | 14,007.0 | 15,613.1 | 13,570.3 |
| Other Noncurrent Assets | 18,013.1 | 19,076.6 | 14,943.0 |
| Total Assets | 57,013.5 | 61,891.3 | 50,037.9 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | 8,792.3 | 9,704.0 | 9,538.4 |
| Short-Term Debt | 1,383.6 | 6,995.0 | 1,406.0 |
| Other Current Liabilities | 4,321.6 | 3,952.7 | 3,281.9 |
| Total Current Liabilities | 14,497.6 | 20,651.7 | 14,226.3 |
| Long-Term Debt | 22,043.8 | 14,107.9 | 9,344.5 |
| Other Noncurrent Liabilities | 8,993.5 | 7,961.2 | 8,087.4 |
| Total Liabilities | 45,535.0 | 42,720.8 | 31,658.2 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 11,478.5 | 19,170.5 | 18,379.7 |
| Total Equity | 11,478.5 | 19,170.5 | 18,379.7 |
| Shares Outstanding (mil.) | 2,830.7 | 2,830.7 | 2,830.7 |
© 2009 Morningstar, Inc. Financial Data provided by
